A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tasimelteon D5 | CAS 1962124-51-1 - Request Quote

Picture of Tasimelteon D5

Tasimelteon D5

SZ CAT No:SZ-T050D01
CAS No
1962124-51-1
Mol.F.
C15H14D5NO2
Mol.Wt.
250.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Tasimelteon D5 is chemically N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propanamide. Tasimelteon D5 is supplied with detailed characterization data compliant with regulatory guideline. Tasimelteon D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tasimelteon.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1962124-51-1

Purchase 1962124-51-1

Order 1962124-51-1

Enquire 1962124-51-1

price of 1962124-51-1

1962124-51-1 Supplier

1962124-51-1 Manufacturer

1962124-51-1 Exporter

buy high quality Tasimelteon D5

Purchase Tasimelteon D5

Tasimelteon D5 suppliers

Tasimelteon D5 manufacturers

Tasimelteon D5 price

Order Tasimelteon D5

Enquire Tasimelteon D5

Tasimelteon D5 cost

Tasimelteon D5 Supplier

Tasimelteon D5 Distributor

Tasimelteon D5 for Method Validation

Tasimelteon Reference Standard

Tasimelteon D5 for ANDA Filing

Tasimelteon D5 for Forced Degradation Studies

Tasimelteon D5 Identification Standards

Tasimelteon D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,